Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Mariona Cabo, Rienk Offringa, Laurence Zitvogel, Guido Kroemer, Aura Muntasell & Lorenzo Galluzzi. (2017) Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications. OncoImmunology 6:12.
Read now
Read now
Articles from other publishers (18)
Suman Kumar Ray & Sukhes Mukherjee. (2023) Altering Landscape of Cancer Vaccines: Unique Platforms, Research on
Therapeutic Applications and Recent Patents. Recent Patents on Anti-Cancer Drug Discovery 18:2, pages 133-146.
Crossref
Crossref
Christine Grimaldi, Alex Ibraghimov, Andrea Kiessling, Benno Rattel, Changhua Ji, Claudette L. Fuller, Frank R. Brennan, Franziska Regenass-Lechner, Jacintha Shenton, Karen D. Price, Marie-Soleil Piché, Meredith A. Steeves, Rodney Prell, Sherri Dudal, Sven Kronenberg, Wendy Freebern & Diann Blanset. (2023) Current nonclinical approaches for immune assessments of immuno-oncology biotherapeutics. Drug Discovery Today 28:2, pages 103440.
Crossref
Crossref
Tingkai Chen, Tianyu Sun, Yaoyao Bian, Yuqiong Pei, Feng Feng, Heng Chi, Yuan Li, Xu Tang, Shenghu Sang, Chenxi Du, Ying Chen, Yao Chen & Haopeng Sun. (2022) The Design and Optimization of Monomeric Multitarget Peptides for the Treatment of Multifactorial Diseases. Journal of Medicinal Chemistry 65:5, pages 3685-3705.
Crossref
Crossref
Cherylette Anne Alexander & Yi Yan Yang. (2022) Harnessing the combined potential of cancer immunotherapy and nanomedicine: A new paradigm in cancer treatment. Nanomedicine: Nanotechnology, Biology and Medicine 40, pages 102492.
Crossref
Crossref
Bin Zheng, Pu Zhang, Heng Wang, Jinxue Wang, Zheng Hong Liu & DaHong Zhang. (2021) Advances in Research on Bladder Cancer Targeting Peptides: a Review. Cell Biochemistry and Biophysics 79:4, pages 711-718.
Crossref
Crossref
Mohammad Kaisarul Islam & Johnson Stanslas. (2021) Peptide-based and small molecule PD-1 and PD-L1 pharmacological modulators in the treatment of cancer. Pharmacology & Therapeutics 227, pages 107870.
Crossref
Crossref
Santiago Correa, Abigail K. Grosskopf, Hector Lopez Hernandez, Doreen Chan, Anthony C. Yu, Lyndsay M. Stapleton & Eric A. Appel. (2021) Translational Applications of Hydrogels. Chemical Reviews 121:18, pages 11385-11457.
Crossref
Crossref
Prakash Lingasamy & Tambet Teesalu. 2021. Bio-Nanomedicine for Cancer Therapy. Bio-Nanomedicine for Cancer Therapy
29
48
.
David M. Richards, Viola Marschall, Katharina Billian-Frey, Karl Heinonen, Christian Merz, Mauricio Redondo Müller, Julian P. Sefrin, Matthias Schröder, Jaromir Sykora, Harald Fricke, Oliver Hill, Christian Gieffers & Meinolf Thiemann. (2019) HERA-GITRL activates T cells and promotes anti-tumor efficacy independent of FcγR-binding functionality. Journal for ImmunoTherapy of Cancer 7:1.
Crossref
Crossref
Patrick Chames & Thierry Wurch. (2020)
Les anticorps et
scaffold
bispécifiques, des médicaments innovants en oncologie impliquant le ciblage des cellules immunitaires
. médecine/sciences 35:12, pages 1072-1082.
Crossref
Crossref
Eva Leufven & Øystein Bruserud. (2019) Immunosuppression and Immunotargeted Therapy in Acute Myeloid Leukemia - The Potential Use of Checkpoint Inhibitors in Combination with Other Treatments. Current Medicinal Chemistry 26:28, pages 5244-5261.
Crossref
Crossref
Meinolf Thiemann, David M. Richards, Karl Heinonen, Michael Kluge, Viola Marschall, Christian Merz, Mauricio Redondo Müller, Tim Schnyder, Julian P. Sefrin, Jaromir Sykora, Harald Fricke, Christian Gieffers & Oliver Hill. (2018) A Single-Chain-Based Hexavalent CD27 Agonist Enhances T Cell Activation and Induces Anti-Tumor Immunity. Frontiers in Oncology 8.
Crossref
Crossref
Vadim Le Joncour & Pirjo Laakkonen. (2018) Seek & Destroy, use of targeting peptides for cancer detection and drug delivery. Bioorganic & Medicinal Chemistry 26:10, pages 2797-2806.
Crossref
Crossref
Frank R. Brennan & Andrea Kiessling. (2017) In vitro assays supporting the safety assessment of immunomodulatory monoclonal antibodies. Toxicology in Vitro 45, pages 296-308.
Crossref
Crossref
Anna Konstorum, Anthony T. Vella, Adam J. Adler & Reinhard C. Laubenbacher. (2017) Addressing current challenges in cancer immunotherapy with mathematical and computational modelling. Journal of The Royal Society Interface 14:131, pages 20170150.
Crossref
Crossref
Ruth J. Davis, Robert L. Ferris & Nicole C. Schmitt. (2016) Costimulatory and coinhibitory immune checkpoint receptors in head and neck cancer: unleashing immune responses through therapeutic combinations. Cancers of the Head & Neck 1:1.
Crossref
Crossref
Jack M Bourke, Michael O'Sullivan & Muhammad A Khattak. (2016) Management of adverse events related to new cancer immunotherapy (immune checkpoint inhibitors). Medical Journal of Australia 205:9, pages 418-424.
Crossref
Crossref
Frank R. Brennan & Andrea Kiessling. (2016) Translational immunotoxicology of immunomodulatory monoclonal antibodies. Drug Discovery Today: Technologies 21-22, pages 85-93.
Crossref
Crossref